Pan 2005.

Methods	Eight‐week, (likely) randomised study.
Participants	In‐patients with depression according to CCMD‐ III criteria.
Interventions	Citalopram: 30 participants. Paroxetine: 30 participants. Venlafaxine: 30 participants. Citalopram dose range: 20‐60 mg/day. Paroxetine dose range: 20‐50 mg/day. Venlafaxine dose range: 75‐375 mg/day.
Outcomes	Change in Hamilton Depression Rating Scale (HDRS) from baseline to endpoint, number of patients who responded to treatment.
Notes	Waiting for translation from Chinese to English (only abstract available in English).